Latest Articles

MS pulse reels - Identifying SPMS with no relapses

MS progression can occur even without relapses or new MRI activity. Discover how to identify  SPMS with no relapses  using a structured clinical approach 

CRSwNP EVEREST

What has been your experience with switching patients from alglucosidase alfa to avalglucosidase alfa?

Current Treatment Landscape & hands on Experience

Thank You!

The End

What makes avalglucosidase alfa different from alglucosidase alfa in terms of clinical efficacy and patient outcomes?

Advances in Therapy: Avalglucosidase Alfa & Future Innovations

How can you see changing the lives of patient starting taking Nexviazyme and if you can share from your experience couple of patient stories that realy impacted positively from staring the treatment for Pompe disease?

From your experience

How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?

What factors influence your decision to switch a patient from alglucosidase alfa to avalglucosidase alfa?

What challenges do clinicians face in monitoring in disease progrission and response to therapy?